New drug aims to fix chemo side effect and keep cancer treatment on track

NCT ID NCT06456528

Recruiting now Symptom relief Sponsor: Qilu Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated May 20, 2026 · Updated 15 times

Summary

This study tests an experimental drug called QL0911 for cancer patients whose platelet levels drop too low after chemotherapy. Low platelets can delay treatment and cause bleeding risks. The trial will compare the drug to a placebo in 235 adults aged 18-75 to see if it safely raises platelet counts and helps patients finish their chemo on schedule.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Harbin First Hospital
RECRUITING

Harbin, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Nanjing Tianyinshan Hospital
RECRUITING

Nanjing, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CANCER TREATMENT-INDUCED THROMBOCYTOPENIA